Michael Gale, Jr., from the University of Washington School of Medicine, and coauthors, evaluated the actions of a specific RIG-I agonist RNA against two distinct human hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback